Want to see SE:ISOFOL full AI Analyst Report?
Isofol Medical AB (ISOFOL) Income Statement
Isofol Medical AB Income Statement
Last quarter (Q2 2026), Isofol Medical AB's total revenue was $0.00. In Q2, Isofol Medical AB's net income was $-15.73M. See Isofol Medical AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 721.00K | $ 12.80M | $ 22.41M | |
| $ 0.00 | $ -38.73M | $ -34.41M | $ -165.71M | $ -174.31M | |
| $ 54.76M | $ 8.47M | $ 7.27M | $ 180.26M | $ 30.16M | |
| Depreciation and Amortization | $ 0.00 | $ 3.00K | $ 37.00K | $ 67.00K | $ 1.60M |
| $ -54.76M | $ -47.21M | $ -37.02M | $ -159.73M | $ -198.49M | |
| $ -54.76M | $ -47.21M | $ -41.68M | $ -167.46M | $ -204.47M | |
| $ 593.00K | $ 3.72M | $ 4.61M | $ 7.75M | $ 4.21M | |
| $ -54.17M | $ -43.49M | $ -37.07M | $ -159.75M | $ -200.25M | |
| $ -54.17M | $ -43.49M | $ -37.07M | $ -159.79M | $ -200.25M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.25 | $ -0.27 | $ -0.23 | $ -0.99 | $ -1.59 |
| Diluted EPS | $ -0.25 | $ -0.27 | $ -0.23 | $ -0.99 | $ -1.59 |
| Weighted Average Shares Outstanding | 216.67M | 161.07M | 161.18M | 161.52M | 125.65M |
| Weighted Average Shares Outstanding (Diluted) | 216.67M | 161.07M | 161.52M | 161.52M | 125.65M |
Currency in SEK
